中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2015年
16期
18-19,20
,共3页
瘢痕子宫%再次妊娠%经阴道分娩%可行性%安全性
瘢痕子宮%再次妊娠%經陰道分娩%可行性%安全性
반흔자궁%재차임신%경음도분면%가행성%안전성
Scarred uterus%Re-pregnancy%Vaginal delivery%Feasibility%Safety
目的:探讨瘢痕子宫再次妊娠经阴道分娩的可行性及安全性。方法60例瘢痕子宫再次妊娠经阴道分娩产妇设为实验组,选择同期分娩的60例非瘢痕子宫再次妊娠经阴道分娩产妇设为对照组,比较两组分娩情况、分娩结局及并发症情况。结果实验组产妇分娩成功率91.7%低于对照组95.0%;两组产妇存活率均为100.0%,差异均无统计学意义(P>0.05);实验组产程、产时出血量、新生儿Apgar评分与对照组相比,差异均无统计学意义(P>0.05);实验组分娩并发症发生率38.3%高于对照组的18.3%(P<0.05)。结论瘢痕子宫再次妊娠经阴道分娩临床上可行性较强,安全性较高,能够减轻产妇痛苦,降低术后并发症发生率,值得推广应用。
目的:探討瘢痕子宮再次妊娠經陰道分娩的可行性及安全性。方法60例瘢痕子宮再次妊娠經陰道分娩產婦設為實驗組,選擇同期分娩的60例非瘢痕子宮再次妊娠經陰道分娩產婦設為對照組,比較兩組分娩情況、分娩結跼及併髮癥情況。結果實驗組產婦分娩成功率91.7%低于對照組95.0%;兩組產婦存活率均為100.0%,差異均無統計學意義(P>0.05);實驗組產程、產時齣血量、新生兒Apgar評分與對照組相比,差異均無統計學意義(P>0.05);實驗組分娩併髮癥髮生率38.3%高于對照組的18.3%(P<0.05)。結論瘢痕子宮再次妊娠經陰道分娩臨床上可行性較彊,安全性較高,能夠減輕產婦痛苦,降低術後併髮癥髮生率,值得推廣應用。
목적:탐토반흔자궁재차임신경음도분면적가행성급안전성。방법60례반흔자궁재차임신경음도분면산부설위실험조,선택동기분면적60례비반흔자궁재차임신경음도분면산부설위대조조,비교량조분면정황、분면결국급병발증정황。결과실험조산부분면성공솔91.7%저우대조조95.0%;량조산부존활솔균위100.0%,차이균무통계학의의(P>0.05);실험조산정、산시출혈량、신생인Apgar평분여대조조상비,차이균무통계학의의(P>0.05);실험조분면병발증발생솔38.3%고우대조조적18.3%(P<0.05)。결론반흔자궁재차임신경음도분면림상상가행성교강,안전성교고,능구감경산부통고,강저술후병발증발생솔,치득추엄응용。
Objective To investigate the feasibility and safety of scarred uterus re-pregnancy by vaginal delivery.Methods There were 60 puerpera with scarred uterus re-pregnancy by vaginal delivery as experimental group, and another 60 puerpera in the same period with non-scarred uterus re-pregnancy by vaginal delivery as control group. Delivery condition, outcomes and complications were analyzed in the two groups.Results The delivery success rate in the experimental group was 91.7%, which was lower than 95.0% in the control group. Both groups had puerperal survival rate as 100.0%, and their differences all had no statistical significance (P>0.05). The differences of stages of labor, intrapartum bleeding volume, and neonatal Apgar score between the two groups all had no statistical significance (P>0.05). The experimental group had higher incidence of delivery complications as 38.3% than 18.3% of the control group (P<0.05).Conclusion Feasibility and safety of scarred uterus re-pregnancy by vaginal delivery are clinically high enough for relieving pain in puerpera and reducing postoperative complications, and it is worthy of promotion and application.